Request Dataset
Contact us
Sign in
Lookup
HS API
Service Map
Crosswalk
Validation
Products
Prior Authorization
Businesses
Data Library
CMS Forms
Home
Healthcare Lookup Services
HCPCS Codes Lookup
G0283 | Similar
HCPCS Codes Similar to G0283
HCPCS Codes Similar to “G0283” Code.
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care
G0281
Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care
Code added date
: 20030401
Code effective date
: 20030401
TXT
|
PDF
|
XML
|
JSON
G0282
Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281
Code added date
: 20030401
Code effective date
: 20030401
TXT
|
PDF
|
XML
|
JSON
G0398
Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation
Code added date
: 20080313
Code effective date
: 20080313
TXT
|
PDF
|
XML
|
JSON
G0399
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation
Code added date
: 20080313
Code effective date
: 20080313
TXT
|
PDF
|
XML
|
JSON
G0400
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels
Code added date
: 20080313
Code effective date
: 20080313
TXT
|
PDF
|
XML
|
JSON
G0465
Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)
Code added date
: 20210413
Code effective date
: 20230701
TXT
|
PDF
|
XML
|
JSON
G0472
Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
Code added date
: 20140602
Code effective date
: 20160101
TXT
|
PDF
|
XML
|
JSON
G9361
Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]
Code added date
: 20140101
Code effective date
: 20220101
TXT
|
PDF
|
XML
|
JSON
G9529
Patient with minor blunt head trauma had an appropriate indication(s) for a head ct
Code added date
: 20160101
Code effective date
: 20160101
TXT
|
PDF
|
XML
|
JSON
G9533
Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct
Code added date
: 20160101
Code effective date
: 20160101
TXT
|
PDF
|
XML
|
JSON
G9355
Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)
Code added date
: 20140101
Code effective date
: 20220101
TXT
|
PDF
|
XML
|
JSON
G9356
Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)
Code added date
: 20140101
Code effective date
: 20220101
TXT
|
PDF
|
XML
|
JSON
M0235
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0236
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON